The convergence of technology, pharmaceutical, and structural interventions to optimally manage disease at the level of the individual is becoming increasingly important. Medical device technology and device-enabled services are increasingly providing the tools and products to optimize the care for the patient, independent of location.
The regulatory and funding environment for medical technologies is rapidly evolving. Increased regulatory uncertainty and market competition has hindered capital raising for medical technology companies. To gain a competitive edge, a company needs to be represented by an investment bank that has both experience in medical technology investment as well as a global network of senior level investors. That is the Culver advantage a company requires in today’s private capital markets.
Depending upon market needs and product merit, Culver represents various MedTech segments, such as:
- mHealth
- Diagnostic Tools and Platforms
- Medical Devices-Surgical
- Medical Devices- Chronic Disease
- Medical Devices- Preventative
- Research Tools
